Protein based COVID-19 vaccine

Description

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant

Dr Sushil Pant

Frozen Shoulder – A Practical Guide to Assessment and Management

Dr Robert Hungerford

Dr Robert Hungerford

Implementing the Four Pillars of Heart Failure Management in GP

Prof Robert Norman

Prof Robert Norman

PCOS Update

Dr Clare Tiedeman

Dr Clare Tiedeman

Biologics in COPD – 20% of Your Patients Could Benefit

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 12 July 2023